Management of Pregnancy & Labour in Valvular Rheumatic Heart Disease
RHD in pregnancy is primarily a hemodynamic problem — increases in plasma volume, heart rate, and cardiac
output can unmask or worsen valve obstruction/regurgitation and precipitate heart failure and arrhythmias.
Outcomes correlate strongly with lesion severity, baseline NYHA class, and prior decompensation — the core
message is early risk stratification, multidisciplinary planning, and tightly managed intrapartum/postpartum physiology.
ЁЯЪж AT A GLANCE — RISK STRATIFICATION
Risk Drivers
NYHA ≥ II early in pregnancy and/or deterioration during pregnancy
Prior acute decompensated heart failure admission before pregnancy
Multivalve disease (common in RHD)
Severe stenotic lesions (esp. mitral stenosis), pulmonary hypertension, atrial fibrillation
GREEN — Lower risk: NYHA I, mild lesions, no pulmonary HTN/AF
AMBER — Moderate risk: NYHA II, moderate lesions and/or prior intervention
RED — High/very high risk: NYHA III–IV, severe MS/AS, pulmonary HTN, recurrent HF/AF, mechanical valve
ЁЯОп ANTENATAL MANAGEMENT GOALS
Physiology Targets
Avoid tachycardia — protects diastolic filling, critical in mitral stenosis
Maintain euvolemia — "slightly dry" often safer than overloaded in MS
Prevent / rapidly treat pulmonary edema and arrhythmias
Reduce thromboembolism risk (AF, large LA, mechanical valve)
Surveillance Across Trimesters
BaselineEcho + ECG; repeat if symptoms change or mod–severe disease
Each VisitFunctional assessment: NYHA, orthopnea, exertional symptoms
If HF/StenosisFetal growth surveillance (placental hypoperfusion risk)
Meds: diuretics for congestion (cautious dosing); rate control for AF/MS; individualized anticoagulation (cardio-ob + hematology)
Secondary prevention: continue rheumatic fever prophylaxis (e.g., long-acting penicillin programs)
ЁЯЪи ESCALATE / ADMIT —
RED FLAGS
New/worsening dyspnea at rest, orthopnea/PND, pulmonary edema
Resting tachycardia, new AF/flutter, syncope
SpO₂ drop, rising BNP, ↑ pulmonary pressures on echo
Hemoptysis (severe MS/pulmonary HTN)
Recurrent admissions / cannot maintain euvolemia as outpatient
ЁЯЧУ️ DELIVERY PLANNING
Vaginal delivery preferred for most stable valvular disease; cesarean reserved for obstetric indications or selected cardiac indications (decompensated severe stenosis, severe pulmonary HTN, inability to tolerate labor)
Vaginal delivery with epidural is commonly recommended for stable disease
Plan early with a Pregnancy Heart Team — cardiology + MFM/obstetrics + anesthesia + neonatology
Timing: aim for controlled, planned delivery — avoid emergency physiology when possible.
ЁЯй║ INTRAPARTUM CHEAT SHEET
Hemodynamic Goals in Labour
1
Maintain preload — avoid sudden venodilation
2
Avoid tachycardia + pain-driven catecholamine surges
3
Avoid fluid overload — strict I&O, judicious IV fluids
4
Maintain oxygenation; treat pulmonary edema early
Analgesia: early neuraxial (epidural), titrated slowly to avoid abrupt SVR/preload shifts; blunts sympathetic surge, reduces Valsalva urge. 2nd stage: avoid prolonged Valsalva; consider assisted vaginal delivery to shorten it (esp. MS).
GREEN: Standard monitoring + careful fluids
AMBER/RED: Arterial line, continuous ECG, strict output, low threshold for ICU/HDU postpartum
Uterotonics: prefer controlled oxytocin (avoid large bolus); avoid ergot derivatives in significant pulmonary HTN/valvular disease (local protocols apply).
Mitral Stenosis
Avoid tachycardia; maintain sinus rhythm if possible
Diurese congestion carefully; avoid overload
If refractory / PH despite therapy: consider PBMV/BMV at experienced centers; combined cesarean + BMV reported feasible in late presenters
Mitral / Aortic Regurgitation
Often better tolerated than stenosis, but decompensation can occur
Manage HF symptoms & arrhythmias promptly
Avoid excessive afterload increases
Aortic Stenosis
Fixed obstruction — avoid hypotension and tachycardia
Delivery / anesthetic plan should be senior-led
Mechanical Valve
"Anticoagulation is the lesion" — high maternal thrombosis & fetal risk
Requires tightly coordinated peripartum anticoagulation plan and timed neuraxial considerations
No comments:
Post a Comment